Cairo – Mubasher: October Pharma on Monday reported a 60% year-on-year rise in profits for 2017 due to a growth in revenues.

Net profit stood at EGP 56 million last year, up from EGP 35 million in 2016, the company said in a filing to the Egyptian Exchange (EGX).

Revenues increased to EGP 350 million in 2017, versus EGP 288 million the previous year.